Grant Street Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-90
Closed -$16K 138
2021
Q1
$16K Buy
90
+72
+400% +$14.3K 0.01% 180
2020
Q4
$2K Buy
+18
New +$1.91K ﹤0.01% 215

Other funds holding NVAX

Grant Street Asset Management's NVAX Position: Q2 2021 in Review

Grant Street Asset Management sold out of Novavax (NVAX) in Q2 2021, closing a stake of 90 shares — an estimated $16K sold.

Grant Street Asset Management first reported a position in NVAX in Q4 2020 and held it in 2 quarters. The position peaked at $16K in Q1 2021. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • Grant Street Asset Management reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • Grant Street Asset Management sold 90 Novavax shares in Q2 2021, an estimated $16K.
  • Grant Street Asset Management first reported a position in Novavax in Q4 2020 and held it in 2 quarters.
  • Grant Street Asset Management's Novavax position peaked at $16K in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Grant Street Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.